美國藥物研究和生產聯合會(PhRMA)

獲取這些結果的RSS提要

此分類的故事和資料

其他文章
15 October 2014
+ English - 隱藏

作者: CBS 60 Minutes (USA)

"The Cost of Cancer Drugs", 5 Oct 2014...

了解更多

文章
10 September 2013
+ English - 隱藏

作者: Sebastian Krueger, Open Society Foundations

Patent protections allow for inflated monopoly pricing and keep generic drugs, which are cheaper, from going to market. Secret international trade deals impose the pharmaceutical companies’ high prices on foreign nations...But Fire in the Blood asks us...

了解更多

文章
21 September 2011
+ English - 隱藏

作者: David Brown, Washington Post

Behind...talks at the United Nations and a...document about the need to fight noncommunicable diseases...is a fierce struggle between commercial and health interests...Some of the issues...are the same ones at the heart of...the battle against smoking...

了解更多

資料
23 February 2009
+ English - 隱藏
文章
23 February 2009
+ English - 隱藏

作者: Global Health Progress Initiative

Promoting health among the world's poorest populations brought leaders from various nations, the global health community, biopharmaceutical companies, the media and international non-governmental organizations (NGOs) together today... The United...

了解更多

文章
23 February 2009
+ English - 隱藏
文章
23 June 2007
+ English - 隱藏

作者: Bloomberg

Thailand plans to buy more generic AIDS drugs from India to cut the cost of treating its poorest patients after failing to win large enough discounts from drug makers including Merck & Co. and Abbott Laboratories…Public health minister, Mongkol Na...

了解更多

文章
14 February 2007
+ English - 隱藏

作者: Keya Acharya, Inter Press Service

Under the drug regulatory process any drug, whether patented or not, must pass safety, efficacy and quality tests for marketing from the Drug Controller-General of India (DGCI)...the DGCI can [currently] rely on previous test data to approve subsequent...

了解更多

文章
3 January 2007
+ English - 隱藏

作者: John Carreyrou, The Wall Street Journal [USA]

In the fall of 2003, Abbott Laboratories...seized on an unusual weapon that helped [its AIDS drug] Kaletra's global sales top $1 billion a year, even as it exposed Abbott to criticism that it was endangering patients. The weapon was an older Abbott...

了解更多

文章
31 May 2005
+ English - 隱藏

作者: Alex Berenson, New York Times

When the drug industry came under fire last summer for failing to disclose poor results from studies of antidepressants, major drug makers promised to provide more information about their research on new medicines...Eli Lilly and some other companies...

了解更多